购物车
- 全部删除
- 您的购物车当前为空
WAY262611是一种 Wnt/β- 联蛋白激动剂,也是一种Dkk1的抑制剂。它能够增加骨形成速率,在 TCF- 荧光素酶测定实验中的EC50=0.63 μM。
为众多的药物研发团队赋能,
让新药发现更简单!
WAY262611是一种 Wnt/β- 联蛋白激动剂,也是一种Dkk1的抑制剂。它能够增加骨形成速率,在 TCF- 荧光素酶测定实验中的EC50=0.63 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 143 | 现货 | |
5 mg | ¥ 355 | 现货 | |
10 mg | ¥ 473 | 现货 | |
25 mg | ¥ 942 | 现货 | |
50 mg | ¥ 1,780 | 现货 | |
100 mg | ¥ 2,590 | 现货 | |
200 mg | ¥ 3,690 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 392 | 现货 |
产品描述 | WAY262611 is a Wnt/β-catenin agonist and an inhibitor of Dkk1. It increases bone formation rate with EC50 of 0.63 μM in TCF-luciferase assay. |
靶点活性 | β-catenin (TCF-Luciferase assay):0.63 μM |
体外活性 | WAY-262611在初级检测中显示出了最强的活性、较低的激酶抑制潜力和高溶解性[1]。 |
体内活性 | WAY-262611具有出色的药代动力学特性,在剂量依赖的方式下,口服给药后可显著提高去卵巢大鼠的椎骨形成速率。采用WAY-262611处理的wt小鼠颅骨显示,骨形成速率(BFR)统计上有显著提升,但同样处理的KO动物与对照组无明显差异。这表明WAY-262611主要通过Wnt β-catenin途径发挥作用,很可能通过抑制Dkk-1[1]来实现。 |
激酶实验 | PI3K and mTOR kinase assay : Enzyme assays are done in fluorescent polarization (FP) format, adapted from the Echelon K-1100 PI3K FP assay kit protocol. Human class I PI3Ks and PI3K-α mutants (E545K and H1047R) are produced in Sf9 or purchased from Upstate Biotech. GST-GRP1 (murine) is produced in Escherichia coli and isolated by GST-Sepharose. Assay buffers are reaction buffer [20 mM HEPES (pH 7.1), 2 mM MgCl2, 0.05% CHAPS, and 0.01% β-mercaptoethanol] and stop/detection buffer [100 mM HEPES (pH 7.5), 4 mM EDTA, 0.05% CHAPS]. FP reaction is run for 30 minutes at room temperature in 20 μL of reaction buffer containing 20 μM phosphatidylinositol 4,5-bisphosphate (PIP2), 25 μM ATP, and <4% DMSO. FP reaction is stopped with 20 μL of stop/detection buffer (10 nM probe and 40 nM GST-GRP), and after 2 hours, data are collected using an Envision plate reader. The routine assays with purified FLAG-TOR (FL and 3.5) are performed in 96-well plates as follows. Enzymes are first diluted in kinase assay buffer (10 mM Hepes (pH 7.4), 50 mM NaCl, 50 mM β-glycerophosphate, 10 mM MnCl2, 0.5 mM DTT, 0.25 μM microcystin LR, and 100 μg/mL BSA). To each well, 12 μL of the diluted enzyme is mixed briefly with 0.5 μL test inhibitor or control vehicle dimethyl sulfoxide (DMSO). The kinase reaction is initiated by adding 12.5 μL kinase assay buffer containing ATP and His6-S6K to give a final reaction volume of 25 μL containing 800 ng/mL FLAG-TOR, 100 μM ATP, and 1.25 μM His6-S6K. The reaction plate is incubated for 2 hours (linear at 1–6 hours) at room temperature with gentle shaking and then terminated by adding 25 μL Stop buffer (20 mM Hepes (pH 7.4), 20 mM EDTA, and 20 mM EGTA). |
分子量 | 318.42 |
分子式 | C20H22N4 |
CAS No. | 1123231-07-1 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 42 mg/mL (131.90 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.